Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons
2011

Brimonidine Protects Retinal Neurons from Damage in Glaucoma

Sample size: 16 publication 10 minutes Evidence: high

Author Information

Author(s): Wendi S Lambert, Lupe Ruiz, Samuel D Crish, Larry A Wheeler, David J Calkins

Primary Institution: The Vanderbilt Eye Institute, Vanderbilt University Medical Center

Hypothesis

Does brimonidine preserve retinal ganglion cell axonal transport and prevent degeneration in a rat model of elevated ocular pressure?

Conclusion

Brimonidine treatment significantly improved retinal ganglion cell survival and axonal transport in rats with elevated ocular pressure.

Supporting Evidence

  • Brimonidine treatment prevented a 44% decrease in ganglion cell uptake of cholera toxin.
  • There was a 33% loss of ganglion cell axons in vehicle-treated rats, which was prevented by brimonidine.
  • Brimonidine improved axonal transport to the superior colliculus by 124% compared to vehicle treatment.

Takeaway

Brimonidine is a medicine that helps protect important eye cells from getting hurt when the pressure in the eye is too high.

Methodology

Rats were treated with brimonidine or a vehicle for 8 weeks after inducing elevated ocular pressure, and various measures of retinal ganglion cell health were assessed.

Limitations

The study was conducted in a rat model, which may not fully replicate human glaucoma.

Participant Demographics

Male Sprague-Dawley rats, weight range 350-400 g.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1750-1326-6-4

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication